{
    "2020-03-23": [
        [
            {
                "time": "2018-03-26",
                "original_text": "US Indexes Close Lower Monday",
                "features": {
                    "keywords": [
                        "Indexes",
                        "Close",
                        "Lower"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-27",
                "original_text": "Dow's 486-point drop led by losses in Chevron, United Technologies stocks",
                "features": {
                    "keywords": [
                        "Dow",
                        "486-point",
                        "drop",
                        "Chevron",
                        "United Technologies"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "energy",
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-03-18",
                "original_text": "These 15 companies are working on coronavirus treatments or vaccines — here’s where things stand",
                "features": {
                    "keywords": [
                        "companies",
                        "coronavirus",
                        "treatments",
                        "vaccines"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-28",
                "original_text": "Dow's 550-point fall led by losses in United Technologies, Chevron shares",
                "features": {
                    "keywords": [
                        "Dow",
                        "550-point",
                        "fall",
                        "United Technologies",
                        "Chevron"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "energy",
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-29",
                "original_text": "United Technologies, Chevron share losses contribute to Dow's 311-point fall",
                "features": {
                    "keywords": [
                        "United Technologies",
                        "Chevron",
                        "share losses",
                        "Dow",
                        "311-point",
                        "fall"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "energy",
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-01-21",
                "original_text": "Glaxo's Long-Acting HIV Regimen Cabenuva Gets Canada's Nod",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Long-Acting",
                        "HIV",
                        "Regimen",
                        "Cabenuva",
                        "Canada's Nod"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-02-15",
                "original_text": "52-Week Company Lows",
                "features": {
                    "keywords": [
                        "52-Week",
                        "Company",
                        "Lows"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-03-10",
                "original_text": "Intra-Cellular prices schizophrenia drug at $1,320 per month",
                "features": {
                    "keywords": [
                        "Intra-Cellular",
                        "schizophrenia",
                        "drug",
                        "$1,320",
                        "per month"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}